Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases
Clinical trial NCT00204581 · COMPLETED
Trial details
- NCT number
- NCT00204581
- Sponsor
- University Hospital Tuebingen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2009-01-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.